Saravut (John) Weroha, MD, PhD

  • 1257 Citations
  • 17 Scopus h-Index
20012019

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 1257 Citations
  • 17 Scopus h-Index
  • 35 Article
  • 5 Review article
  • 1 Letter
Filter
Review article
2015

Multi-targeted kinase inhibitor sorafenib and its future

Gil, M., Weroha, S. J., Iyer, R. & Opyrchal, M., 2015, In : Cancer and Chemotherapy Reviews. 10, 1, p. 16-24 9 p.

Research output: Contribution to journalReview article

2012

Oncogenic pathways, molecularly targeted therapies, and highlighted clinical trials in non-small-cell lung cancer (NSCLC)

Reungwetwattana, T., Weroha, S. J. & Molina, J. R., Jul 1 2012, In : Clinical lung cancer. 13, 4, p. 252-266 15 p.

Research output: Contribution to journalReview article

90 Scopus citations

The Insulin-Like Growth Factor System in Cancer

Weroha, S. J. & Haluska, P., Jun 1 2012, In : Endocrinology and Metabolism Clinics of North America. 41, 2, p. 335-350 16 p.

Research output: Contribution to journalReview article

103 Scopus citations
2008

IGF-1 receptor inhibitors in clinical trials - Early lessons

Weroha, S. J. & Haluska, P., Nov 20 2008, In : Journal of Mammary Gland Biology and Neoplasia. 13, 4, p. 471-483 13 p.

Research output: Contribution to journalReview article

136 Scopus citations
2002

Prevention of solely estrogen-induced mammary tumors in female ACI rats by tamoxifen: Evidence for estrogen receptor mediation

Li, S. A., Weroha, S. J., Tawfik, O. & Li, J. J., Nov 1 2002, In : Journal of Endocrinology. 175, 2, p. 297-305 9 p.

Research output: Contribution to journalReview article

55 Scopus citations